Anti-LRRTM1 antibodies are used in the immunodetection of the protein leucine rich repeat transmembrane neuronal 1. In humans, the canonical protein has a reported length of 522 amino acid residues and a mass of 58.6 kDa. Its subcellular localization is in the cell membrane. It is reported to be highly expressed in the forebrain regions including thalamus and cerebral cortex. A member of the LRRTM protein family, LRRTM1 is known to be involved with cellular localization. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include leucine-rich repeat transmembrane neuronal 1 protein, and leucine-rich repeat transmembrane neuronal protein 1. LRRTM1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some LRRTM1 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.